Resmetirom AASLD Clinical Data Review Tuesday, November 16th, 2021 8.00 – 9.00am EST Forward Looking Statements Any statements, other than statements of historical facts, made in this presentation are, or may be deemed, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Examples of these forward-looking statements include those concerning: our primary and secondary study endpoints and supportive data for resmetirom, and the potential for achieving such end ...